Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 2,198.00p on 06-02-2026 at 19:35:09
Change 18.00p 0.83%
Buy 2,195.00p
Sell 2,193.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 777.00 at 2,198.00p
Day's Volume: 8,478,262
Last Close: 2,198.00p
Open: 2,166.00p
ISIN: GB00BN7SWP63
Day's Range 2,152.00p - 2,198.00p
52wk Range: 1,242.50p - 2,198.00p
Market Capitalisation: £88.21b
VWAP: 2,184.89107p
Shares in Issue: 4.01b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Higher Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 777 2,198.00p SI Trade
Negotiated Trade
 16:54:35 - 06-Feb-26
Sell* 2,733 2,188.668p SI Trade
Suspected SELL Trade
 16:42:16 - 06-Feb-26
Sell* 3,930 2,198.00p Automatic Execution
 16:35:23 - 06-Feb-26
Sell* 951 2,198.00p SI Trade
 16:35:22 - 06-Feb-26
Sell* 6 2,198.00p SI Trade
 16:35:22 - 06-Feb-26
Sell* 3,418 2,198.00p SI Trade
 16:35:22 - 06-Feb-26
Sell* 34 2,198.00p SI Trade
 16:35:22 - 06-Feb-26
Sell* 10 2,198.00p SI Trade
 16:35:22 - 06-Feb-26
Sell* 1,800 2,198.00p SI Trade
 16:35:22 - 06-Feb-26
Sell* 1,584 2,198.00p SI Trade
 16:35:22 - 06-Feb-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
6th Feb 2026 (Fri) 2,166.00 2,198.00 2,152.00 2,198.00 8,478,262
5th Feb 2026 (Thu) 2,090.00 2,196.00 2,083.00 2,180.00 16,400,217
4th Feb 2026 (Wed) 1,935.50 2,111.00 1,920.00 2,080.00 16,788,662
3rd Feb 2026 (Tue) 1,922.50 1,945.50 1,919.00 1,945.50 6,775,935
2nd Feb 2026 (Mon) 1,882.50 1,927.50 1,875.00 1,925.00 12,846,159
30th Jan 2026 (Fri) 1,836.00 1,876.50 1,823.00 1,876.50 8,924,204
29th Jan 2026 (Thu) 1,812.00 1,859.00 1,811.00 1,852.00 9,993,355
28th Jan 2026 (Wed) 1,842.50 1,851.50 1,810.00 1,817.50 12,027,944
27th Jan 2026 (Tue) 1,834.00 1,865.50 1,832.50 1,862.50 4,702,280
26th Jan 2026 (Mon) 1,802.50 1,833.00 1,795.00 1,828.50 3,634,721
23rd Jan 2026 (Fri) 1,814.00 1,814.00 1,796.00 1,801.00 9,062,710
22nd Jan 2026 (Thu) 1,792.50 1,808.00 1,776.50 1,804.50 4,820,384
21st Jan 2026 (Wed) 1,786.50 1,798.50 1,777.00 1,787.50 6,414,843
20th Jan 2026 (Tue) 1,802.00 1,805.50 1,774.00 1,795.50 7,498,672
19th Jan 2026 (Mon) 1,800.00 1,816.00 1,793.00 1,816.00 5,056,429
16th Jan 2026 (Fri) 1,838.00 1,845.00 1,795.50 1,816.50 14,632,764
15th Jan 2026 (Thu) 1,890.50 1,895.50 1,845.00 1,848.00 4,980,454
14th Jan 2026 (Wed) 1,856.50 1,880.50 1,853.50 1,880.50 6,552,424
13th Jan 2026 (Tue) 1,868.50 1,874.00 1,833.00 1,858.00 5,789,190
12th Jan 2026 (Mon) 1,879.50 1,902.00 1,866.00 1,877.00 5,647,857
9th Jan 2026 (Fri) 1,875.00 1,896.00 1,871.00 1,886.00 6,348,596
8th Jan 2026 (Thu) 1,891.50 1,908.50 1,880.00 1,891.00 6,026,419
7th Jan 2026 (Wed) 1,902.00 1,909.50 1,869.50 1,901.50 7,532,634
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
6th Feb 2026 10:30 am RNS Director/PDMR Shareholding
6th Feb 2026 7:00 am RNS Nucala COPD approved by the European Commission
5th Feb 2026 3:30 pm RNS Director/PDMR Shareholding
4th Feb 2026 7:00 am RNS Final Results
2nd Feb 2026 3:00 pm RNS Total Voting Rights
26th Jan 2026 7:00 am RNS European Commission approves Arexvy for adults 18+
20th Jan 2026 7:05 am RNS GSK to acquire RAPT Therapeutics
20th Jan 2026 7:00 am RNS Agreement on changes to ViiV minority shareholding
16th Jan 2026 3:30 pm RNS Director/PDMR Shareholding
15th Jan 2026 3:30 pm RNS Director/PDMR Shareholding
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

IN BRIEF: GSK Chair Jonathan Symonds buys GBP53,000 in shares

6th Feb 2026 16:18

GSK PLC - London-based pharmaceuticals company - GSK Non-Executive Chair Jonathan Symonds buys 2,500 shares, at a price of GBP21.14, worth GBP52,850, on Thursday in London. Read More

LONDON BROKER RATINGS: Oddo BHF cuts Wizz Air and Ryanair

6th Feb 2026 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON MARKET OPEN: FTSE 100 falls as AI fears pressure data stocks

6th Feb 2026 09:15

(Alliance News) - Stock prices in London opened lower on Friday, as renewed fears around artifical intelligence investment spread from the US while software and data stocks came under pressure. Read More

EU regulator greenlights GSK lung disease therapy Nucala

6th Feb 2026 08:37

(Alliance News) - GSK PLC on Friday said the European Commission has approved Nucala, or mepolizumab, as add-on therapy for adults with chronic obstructive pulmonary disease. Read More

LONDON BRIEFING: UK house prices rise more than expected in January

6th Feb 2026 07:55

(Alliance News) - UK house prices rise more sharply than expected, GSK wins approval for Nucala to treat chronic obstructive pulmonary disease in the EU, while Victrex backs its annual guidance. Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,369.75
Change60.53

Login to your account

Forgot Password?

Not Registered